|
US2887440A
(en)
*
|
1957-08-12 |
1959-05-19 |
Dow Chemical Co |
Enteric coating
|
|
US3065143A
(en)
*
|
1960-04-19 |
1962-11-20 |
Richardson Merrell Inc |
Sustained release tablet
|
|
NL128902C
(https=)
*
|
1960-06-06 |
|
|
|
|
US3458622A
(en)
*
|
1967-04-07 |
1969-07-29 |
Squibb & Sons Inc |
Controlled release tablet
|
|
US3845770A
(en)
*
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
JPS58403B2
(ja)
*
|
1975-07-24 |
1983-01-06 |
武田薬品工業株式会社 |
Ｌ− アスコルビンサンセイザイノ セイゾウホウ
|
|
US4167558A
(en)
*
|
1976-02-13 |
1979-09-11 |
Hoffmann-La Roche Inc. |
Novel sustained release tablet formulations
|
|
US4140755A
(en)
*
|
1976-02-13 |
1979-02-20 |
Hoffmann-La Roche Inc. |
Sustained release tablet formulations
|
|
SE8103843L
(sv)
*
|
1981-06-18 |
1982-12-19 |
Astra Laekemedel Ab |
Farmaceutisk mixtur
|
|
US4424235A
(en)
*
|
1981-09-14 |
1984-01-03 |
Hoffmann-La Roche Inc. |
Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
|
|
US4389393A
(en)
*
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
|
DE3572485D1
(en)
*
|
1984-12-22 |
1989-09-28 |
Thomae Gmbh Dr K |
Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
|
|
US4738851A
(en)
*
|
1985-09-27 |
1988-04-19 |
University Of Iowa Research Foundation, Inc. |
Controlled release ophthalmic gel formulation
|
|
US4709712A
(en)
*
|
1986-10-22 |
1987-12-01 |
Dermatalogical Products Of Texas |
Polycarboxylic acid polymer gels as protective agents
|
|
US4968508A
(en)
*
|
1987-02-27 |
1990-11-06 |
Eli Lilly And Company |
Sustained release matrix
|
|
US4789549A
(en)
*
|
1987-03-09 |
1988-12-06 |
Warner-Lambert Company |
Sustained release dosage forms
|
|
GB8828020D0
(en)
*
|
1988-12-01 |
1989-01-05 |
Unilever Plc |
Topical composition
|
|
US5026559A
(en)
*
|
1989-04-03 |
1991-06-25 |
Kinaform Technology, Inc. |
Sustained-release pharmaceutical preparation
|
|
US5007790A
(en)
*
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5273975A
(en)
*
|
1989-06-09 |
1993-12-28 |
The Upjohn Company |
Heterocyclic amines having central nervous system activity
|
|
IE82916B1
(en)
*
|
1990-11-02 |
2003-06-11 |
Elan Corp Plc |
Formulations and their use in the treatment of neurological diseases
|
|
US5681585A
(en)
*
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
|
US5472712A
(en)
*
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
|
US5656296A
(en)
*
|
1992-04-29 |
1997-08-12 |
Warner-Lambert Company |
Dual control sustained release drug delivery systems and methods for preparing same
|
|
US5731338A
(en)
*
|
1992-07-02 |
1998-03-24 |
Oramed, Inc. |
Controlled release pilocarpine delivery system
|
|
DE4241013A1
(de)
*
|
1992-12-05 |
1994-06-09 |
Boehringer Ingelheim Kg |
Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
|
|
US5431920A
(en)
*
|
1993-09-21 |
1995-07-11 |
Merck Frosst, Canada, Inc. |
Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
|
|
US5458887A
(en)
*
|
1994-03-02 |
1995-10-17 |
Andrx Pharmaceuticals, Inc. |
Controlled release tablet formulation
|
|
US5846971A
(en)
*
|
1996-06-28 |
1998-12-08 |
Schering Corporation |
Oral antifungal composition
|
|
WO1998055107A1
(en)
*
|
1997-06-06 |
1998-12-10 |
Depomed, Inc. |
Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
|
|
US6624200B2
(en)
*
|
1998-08-25 |
2003-09-23 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US6248358B1
(en)
*
|
1998-08-25 |
2001-06-19 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets and methods of making and using the same
|
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
DE69819748T2
(de)
*
|
1997-09-12 |
2004-09-30 |
Columbia Laboratories (Bermuda) Ltd. |
Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
|
|
US6197339B1
(en)
*
|
1997-09-30 |
2001-03-06 |
Pharmacia & Upjohn Company |
Sustained release tablet formulation to treat Parkinson's disease
|
|
US6056977A
(en)
*
|
1997-10-15 |
2000-05-02 |
Edward Mendell Co., Inc. |
Once-a-day controlled release sulfonylurea formulation
|
|
JP2002506031A
(ja)
*
|
1998-03-11 |
2002-02-26 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
組成物
|
|
KR20060056417A
(ko)
*
|
1998-05-15 |
2006-05-24 |
파마시아 앤드 업존 캄파니 엘엘씨 |
프라미펙솔의 신규 용도
|
|
TW407058B
(en)
*
|
1998-07-17 |
2000-10-01 |
Dev Center Biotechnology |
Oral cisapride dosage forms with an extended duration
|
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
EP1169024B1
(en)
*
|
1999-03-31 |
2005-12-21 |
Janssen Pharmaceutica N.V. |
Pregelatinized starch in a controlled release formulation
|
|
DE19927688A1
(de)
*
|
1999-06-17 |
2000-12-21 |
Gruenenthal Gmbh |
Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
|
|
EP1261340B1
(en)
*
|
1999-07-13 |
2009-05-13 |
Alpha Research Group, LLC |
Compositions and methods for the treatment of parkinson's disease
|
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
CN1434713A
(zh)
*
|
1999-12-22 |
2003-08-06 |
法马西亚公司 |
环加氧酶－2抑制剂的缓释制剂
|
|
US6467637B2
(en)
*
|
2000-01-27 |
2002-10-22 |
The York Group, Inc. |
Death care merchandising system
|
|
PE20011074A1
(es)
*
|
2000-02-23 |
2001-10-04 |
Upjohn Co |
Uso de pramipexol en el tratamiento de trastornos de adiccion
|
|
PT1257277E
(pt)
*
|
2000-02-24 |
2005-09-30 |
Pharmacia & Upjohn Co Llc |
Novas combinacoes de farmacos
|
|
US6955821B2
(en)
*
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
|
US6277875B1
(en)
*
|
2000-07-17 |
2001-08-21 |
Andrew J. Holman |
Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
|
|
WO2002011727A1
(en)
*
|
2000-08-08 |
2002-02-14 |
Teva Pharmaceutical Industries Ltd. |
Stable pergolide mesylate and process for making same
|
|
ES2187249B1
(es)
*
|
2000-09-18 |
2004-09-16 |
Synthon Bv |
Procedimiento para la preparacion de 2-amino-6-(alquil)amino-4,5,6,7-tetrahidrobenzotiazoles.
|
|
SE0004671D0
(sv)
*
|
2000-12-15 |
2000-12-15 |
Amarin Dev Ab |
Pharmaceutical formulation
|
|
US20030032661A1
(en)
*
|
2001-08-02 |
2003-02-13 |
Boehringer Ingelheim Pharma Kg |
Pramipexole as an anticonvulsant
|
|
CA2470636A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Pharmacia Corporation |
Zero-order sustained released dosage forms and method of making the same
|
|
US20030215498A1
(en)
*
|
2002-05-17 |
2003-11-20 |
Harland Ronald S. |
Rapidly disintegrating comressed tablets comprising biologically active compounds
|
|
PA8578501A1
(es)
*
|
2002-07-25 |
2005-02-04 |
Pharmacia Corp |
Forma de dosificacion una vez al dia de pramipexol
|
|
US20070196481A1
(en)
*
|
2002-07-25 |
2007-08-23 |
Amidon Gregory E |
Sustained-release tablet composition
|
|
US20050226926A1
(en)
*
|
2002-07-25 |
2005-10-13 |
Pfizer Inc |
Sustained-release tablet composition of pramipexole
|
|
US20040121010A1
(en)
*
|
2002-10-25 |
2004-06-24 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
|
US20050020589A1
(en)
*
|
2003-06-18 |
2005-01-27 |
Pfizer Inc. |
Sustained-release tablet composition comprising a dopamine receptor agonist
|
|
CN101022788B
(zh)
*
|
2004-08-13 |
2010-11-10 |
贝林格尔·英格海姆国际有限公司 |
包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途
|
|
UA93608C2
(ru)
*
|
2004-08-13 |
2011-02-25 |
Берингер Ингельхайм Интернациональ Гмбх |
композициЯ таблетки пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, СПОСОБ EE ИЗГОТОВЛЕНИЯ И EE ПРИМЕНЕНИЕ
|
|
EP1988875A2
(en)
*
|
2006-02-10 |
2008-11-12 |
Boehringer Ingelheim International GmbH |
Modified release formulation
|
|
WO2007090883A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Boehringer Ingelheim International Gmbh |
Extended release formulation
|
|
EP1886665A1
(en)
*
|
2006-08-01 |
2008-02-13 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Gastro retentive delivery system
|
|
CL2007002214A1
(es)
*
|
2006-08-14 |
2008-03-07 |
Boehringer Ingelheim Int |
Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
|
|
KR20090045945A
(ko)
*
|
2006-08-25 |
2009-05-08 |
베링거 인겔하임 인터내셔날 게엠베하 |
제어 방출 시스템 및 이의 제조방법
|